目次

Table of Contents

Chapter 1 Preclinical CRO Market: Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Regional Scope
1.1.2 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective - 1
1.10.2 Objective - 2
1.10.3 Objective - 3
1.10.4 Objective - 4

Chapter 2 Preclinical CRO Market: Executive Summary
2.1 Market Outlook

Chapter 3 Preclinical CRO Market: Variables, Trends, & Scope
3.1 Segment Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.3 Rising R&D offshoring
3.3.1 Rising outsourcing trend
3.3.2 Life sciences companies focusing on their core competencies
3.3.2 Market Restraint Analysis
3.3.2.1 Monitoring issues and lack of standardization
3.4 Preclinical CRO Market Analysis Tools
3.4.1 Porter’s Five Forces Analysis
3.4.2 Industry Analysis Porter’s
3.4.2.1 Competitor rivalry (High)
3.4.2.2 Bargaining power of buyers(high)
3.4.2.3 Bargaining power of suppliers(Low)
3.4.2.4 Threat of substitutes (low)
3.4.2.5 Threat of new entrants (Low)
3.4.3 PESTEL Analysis
3.4.3.1 PESTLE Analysis
3.4.3.1.1 Political And LegaL
3.4.3.1.1.1 Strengths
3.4.3.1.1.2 Weaknesses
3.4.3.1.1.3 Opportunities
3.4.3.1.1.4 Threats
3.4.3.1.2 Economic
3.4.3.1.2.1 Strengths
3.4.3.1.2.2 Weaknesses
3.4.3.1.2.3 Opportunities
3.4.3.1.2.4 Threats
3.4.3.1.3 Social and Environmental
3.4.3.1.3.1 Strengths
3.4.3.1.3.2 Weaknesses
3.4.3.1.3.3 Opportunities
3.4.3.1.3.4 Threats
3.5 COVID-19 Impact Analysis

Chapter 4. Service Business Analysis
4.1. Preclinical CRO Market: Service Movement Analysis
4.2. Bioanalysis and DMPK Studies
4.2.1. Bioanalysis and DMPK Studies Market, 2018 - 2030 (USD Billion)
4.3. In-vitro ADME
4.3.1. In-vitro ADME Market, 2018 - 2030 (USD Billion)
4.4. In-Vivo Pk
4.4.1. In-Vivo Pk Market, 2018 - 2030 (USD Billion)
4.5. Toxicology Testing
4.5.1. Toxicology Testing Market, 2018 - 2030 (USD Billion)
4.5.2. Glp
4.5.2.1. Glp Market, 2018 - 2030 (USD Billion)
4.5.3. Non-Glp
4.5.3.1. Non-Glp Market, 2018 - 2030 (USD Billion)
4.6. Compound Management
4.6.1. Compound Management Companies market, 2018 - 2030 (USD Billion)
4.6.2. Process R&D
4.6.2.1. Process r&D Market, 2018 - 2030 (USD Billion)
4.6.3. Custom Synthesis
4.6.3.1. Custom Synthesis Market, 2018 - 2030 (USD Billion)
4.6.4. Others
4.6.4.1. Others Market, 2018 - 2030 (USD Billion)
4.7. Chemistry
4.7.1. Chemistry Testing Market, 2018 - 2030 (USD Billion)
4.7.2. Medicinal Chemistry
4.7.2.1. Medicinal Chemistry Market, 2018 - 2030 (USD Billion)
4.7.3. Computation Chemistry
4.7.3.1. Computation Chemistry Market, 2018 - 2030 (USD Billion)
4.8. Safety Pharmacology
4.8.1. Safety Pharmacology market, 2018 - 2030 (USD Billion)
4.9. Others
4.9.1. Others market, 2018 - 2030 (USD Billion

Chapter 5. Model Type Business Analysis
5.1. Preclinical CRO Market: Model Type Movement Analysis
5.2. Patient Derived Organoid (PDOs) Models
5.2.1. Patient Derived Organoid (PDOs) Models Market, 2018 - 2030 (USD Billion)
5.3. Patient Derived Xenograft (PDX) Models
5.3.1. Patient Derived Xenograft (PDX) Models Market, 2018 - 2030 (USD Billion)

Chapter 6. End-use Business Analysis
6.1. Preclinical CRO Market: End-use Movement Analysis
6.2. Biopharmaceutical Companies
6.2.1. Biopharmaceutical Companies Market, 2018 - 2030 (USD Billion)
6.3. Government and Academic Institutes
6.3.1. Government and Academic Institutes Validation Market, 2018 - 2030 (USD Billion)
6.4. Medical Device Companies
6.4.1. Medical Device Companies Market, 2018 - 2030 (USD Billion)

Chapter 7. Regional Business Analysis
7.1. Preclinical CROMarket Share By Region, 2023 & 2030
7.2. North America
7.2.1. North America Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Regulatory Framework
7.2.2.3. Competitive Scenario
7.2.2.4. U.S. Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Regulatory Framework
7.2.3.3. Competitive Scenario
7.2.3.4. Canada Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.3. Europe
7.3.1. Europe Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. UK Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Germany Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. France Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Italy Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Spain Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.3.7. Sweden
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Sweden Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.3.8. Norway
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Norway Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.3.9. Denmark
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Denmark Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.4. Asia Pacific
7.4.1. Asia Pacific Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Japan Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. China Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. List of Preclinical CRO in India
7.4.4.4. India Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Australia Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.4.6. South Korea
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. South Korea Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Thailand Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.5. Latin America
7.5.1. Latin America Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Brazil Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Mexico Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Argentina Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.6. MEA
7.6.1. MEA Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. South Africa Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Saudi Arabia Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. UAE Preclinical CRO Market, 2018 - 2030 (USD Billion)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Kuwait Preclinical CRO Market, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.2.1. Merger& Acquisition
8.2.2. Collaborations
8.2.3. New Product Launch
8.3. Participant’s overview
8.3.1. WuXi AppTec, Inc. (WAI)
8.3.1.1. Overview
8.3.1.2. Financial Performance
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. LABCORP
8.3.2.1. Overview
8.3.2.2. Financial Performance
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Eurofins scientific se
8.3.3.1. Overview
8.3.3.2. Financial Performance
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Medpace holdings inc.
8.3.4.1. Overview
8.3.4.2. Financial Performance
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Charles River Laboratories International, Inc.
8.3.5.1. Overview
8.3.5.2. Financial Performance
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Intertek group plc
8.3.6.1. Overview
8.3.6.2. Financial Performance
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. SGA SA
8.3.7.1. Overview
8.3.7.2. Financial Performance
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. PPD (THERMO FISHER SCIENTIFIC, INC.)
8.3.8.1. Overview
8.3.8.2. Financial Performance
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. PRA Health Sciences, INC. (ICON plc)
8.3.9.1. Overview
8.3.9.2. Financial Performance
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. CROWN bioscience
8.3.10.1. Overview
8.3.10.2. Financial Performance
8.3.10.3. Product Benchmarking
8.3.10.4. Strategic Initiatives

List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 4. Global Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 5. Global Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 6. Global Preclinical CRO Market by Region, 2018 - 2030 (USD Billion)
Table 7. North America Preclinical CRO Market by Country, 2018 - 2030 (USD Billion)
Table 8. North America Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 9. North America Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 10. North America Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 11. U.S. Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 12. U.S. Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 13. U.S. Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 14. Canada Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 15. Canada Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 16. Canada Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 17. Europe Preclinical CRO Market by Country, 2018 - 2030 (USD Billion)
Table 18. Europe Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 19. Europe Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 20. Europe Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 21. Germany Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 22. Germany Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 23. Germany Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 24. UK Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 25. UK Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 26. UK Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 27. France Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 28. France Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 29. France Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 30. Italy Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 31. Italy Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 32. Italy Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 33. Spain Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 34. Spain Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 35. Spain Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 36. Denmark Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 37. Denmark Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 38. Denmark Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 39. Sweden Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 40. Sweden Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 41. Sweden Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 42. Norway Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 43. Norway Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 44. Norway Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 45. Asia Pacific Preclinical CRO Market by Country, 2018 - 2030 (USD Billion)
Table 46. Asia Pacific Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 47. Asia Pacific Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 48. Asia Pacific Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 49. China Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 50. China Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 51. China Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 52. Japan Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 53. Japan Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 54. Japan Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 55. India Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 56. India Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 57. India Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 58. South Korea Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 59. South Korea Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 60. South Korea Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 61. Australia Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 62. Australia Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 63. Australia Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 64. Thailand Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 65. Thailand Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 66. Thailand Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 67. Latin America Preclinical CRO Market by Country, 2018 - 2030 (USD Billion)
Table 68. Latin America Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 69. Latin America Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 70. Latin America Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 71. Brazil Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 72. Brazil Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 73. Brazil Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 74. Mexico Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 75. Mexico Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 76. Mexico Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 77. Argentina Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 78. Argentina Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 79. Argentina Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 80. Middle East & Africa Preclinical CRO Market by Country, 2018 - 2030 (USD Billion)
Table 81. Middle East & Africa Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 82. Middle East & Africa Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 83. Middle East & Africa Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 84. South Africa Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 85. South Africa Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 86. South Africa Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 87. Saudi Arabia Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 88. Saudi Arabia Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 89. Saudi Arabia Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 90. UAE Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 91. UAE Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 92. UAE Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)
Table 93. Kuwait Preclinical CRO Market by Service, 2018 - 2030 (USD Billion)
Table 94. Kuwait Preclinical CRO Market by Model Type, 2018 - 2030 (USD Billion)
Table 95. Kuwait Preclinical CRO Market by End-use, 2018 - 2030 (USD Billion)

List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Volume price analysis
Fig. 8 Preclinical CRO market snapshot (2021) (USD Billion)
Fig. 9 Preclinical CRO market segmentation
Fig. 10 Penetration & growth prospect mapping
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Porter’s five forces analysis
Fig. 14 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 15 Preclinical CRO market service outlook: Segment dashboard
Fig. 16 Preclinical CRO market: Service movement analysis
Fig. 17 Bioanalysis and DMPK studies market, 2018 - 2030 (USD Billion)
Fig. 18 In-vitro ADME market, 2018 - 2030 (USD Billion)
Fig. 19 In-vivo PK market, 2018 - 2030 (USD Billion)
Fig. 20 Toxicology testing market, 2018 - 2030 (USD Billion)
Fig. 21 GLP market, 2018 - 2030 (USD Billion)
Fig. 22 Non-GLP market, 2018 - 2030 (USD Billion)
Fig. 23 Non-mammalian source market, 2018 - 2030 (USD Billion)
Fig. 24 Process R&D market, 2018 - 2030 (USD Billion)
Fig. 25 Custom synthesis market, 2018 - 2030 (USD Billion)
Fig. 26 Others market, 2018 - 2030 (USD Billion)
Fig. 27 Chemistry market, 2018 - 2030 (USD Billion)
Fig. 28 Medicinal chemistry market, 2018 - 2030 (USD Billion)
Fig. 29 Computation chemistry market, 2018 - 2030 (USD Billion)
Fig. 30 Safety pharmacology market, 2018 - 2030 (USD Billion)
Fig. 31 Others market, 2018 - 2030 (USD Billion)
Fig. 32 Preclinical CRO market model type outlook: Segment dashboard
Fig. 33 Preclinical CRO market: Model type movement analysis
Fig. 34 Patient derived organoid (PDO) models market, 2018 - 2030 (USD Billion)
Fig. 35 Patient derived xenograft (PDX) models market, 2018 - 2030 (USD Billion)
Fig. 36 Preclinical CRO market end-use outlook: Segment dashboard
Fig. 37 Preclinical CRO market: End-use movement analysis
Fig. 38 Biopharmaceutical companies’ market, 2018 - 2030 (USD Billion)
Fig. 39 Government and academic institutes market, 2018 - 2030 (USD Billion)
Fig. 40 Medical device companies’ market, 2018 - 2030 (USD Billion)
Fig. 41 Regional market: Key takeaways
Fig. 42 Regional outlook, 2021 & 2030
Fig. 43 North America market, 2018 - 2030 (USD Billion)
Fig. 44 U.S. market, 2018 - 2030 (USD Billion)
Fig. 45 Canada market, 2018 - 2030 (USD Billion)
Fig. 46 Europe market, 2018 - 2030 (USD Billion)
Fig. 47 UK market, 2018 - 2030 (USD Billion)
Fig. 48 Germany market, 2018 - 2030 (USD Billion)
Fig. 49 France market, 2018 - 2030 (USD Billion)
Fig. 50 Italy market, 2018 - 2030 (USD Billion)
Fig. 51 Spain market, 2018 - 2030 (USD Billion)
Fig. 52 Denmark market, 2018 - 2030 (USD Billion)
Fig. 53 Sweden market, 2018 - 2030 (USD Billion)
Fig. 54 Norway market, 2018 - 2030 (USD Billion)
Fig. 55 Asia Pacific market, 2018 - 2030 (USD Billion)
Fig. 56 Japan market, 2018 - 2030 (USD Billion)
Fig. 57 China market, 2018 - 2030 (USD Billion)
Fig. 58 India market, 2018 - 2030 (USD Billion)
Fig. 59 Australia market, 2018 - 2030 (USD Billion)
Fig. 60 Thailand market, 2018 - 2030 (USD Billion)
Fig. 61 South Korea market, 2018 - 2030 (USD Billion)
Fig. 62 Latin America market, 2018 - 2030 (USD Billion)
Fig. 63 Brazil market, 2018 - 2030 (USD Billion)
Fig. 64 Mexico market, 2018 - 2030 (USD Billion)
Fig. 65 Argentina market, 2018 - 2030 (USD Billion)
Fig. 66 MEA market, 2018 - 2030 (USD Billion)
Fig. 67 South Africa market, 2018 - 2030 (USD Billion)
Fig. 68 Saudi Arabia market, 2018 - 2030 (USD Billion)
Fig. 69 UAE market, 2018 - 2030 (USD Billion)
Fig. 70 Kuwait Arabia market, 2018 - 2030 (USD Billion)